» Articles » PMID: 32265292

Impact of Radiographic Bronchiectasis in COPD

Overview
Journal Respir Care
Publisher Mary Ann Liebert
Specialty Pulmonary Medicine
Date 2020 Apr 9
PMID 32265292
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: COPD and bronchiectasis frequently coexist, which creates an emerging phenotype with a worse prognosis. However, the impact of bronchiectasis on the natural history of COPD has not been fully evaluated and is still controversial. This meta-analysis was performed to clarify the associations of the presence of bronchiectasis with the prognosis and quality of life of patients with COPD.

Methods: A systematic review and meta-analysis was performed following a search of medical databases, and included articles published up to April 2019. The following outcome measures were analyzed: age, sex, smoking history, body mass index, exacerbation rate, lung function, inflammatory biomarkers, albumin, colonization by potentially pathogenic microorganisms, isolates, isolates, hospital admissions, and mortality.

Results: A total of 415,257 subjects with COPD from 18 observational studies were eligible; bronchiectasis was present in 25,929 subjects (6.24%). The coexistence of COPD and bronchiectasis occurred more often in older subjects with lower body mass index. The presence of bronchiectasis in the subjects with COPD increased the risk of daily sputum production (odds ratio [OR] 1.80, 95% CI 1.24-2.61), exacerbation (weighted mean difference [WMD] 0.72 times, 95% CI 0.59-0.85), frequent hospital admissions (WMD 0.35 times, 95% CI 0.21-0.49), and follow-up (>3 years) mortality (OR 2.26, 95% CI 0.95-5.36). The subjects with COPD and bronchiectasis showed poorer pulmonary function (FEV/FVC: WMD -3.37%, 95% CI -5.63 to -1.11), lower albumin (Standardized mean difference [SMD] -0.17, 95% CI -0.26 to -0.08), elevated C-reactive protein (SMD 0.40, 95% CI 0.06-0.74), a greater proportion of chronic colonization by potentially pathogenic microorganisms (OR 6.65, 95% CI 4.44-9.95), and a higher isolation rate of (OR 5.13, 95% CI 4.89-5.38) or (OR 1.90, 95% CI 1.29-2.79) than the subjects with COPD without bronchiectasis.

Conclusions: This meta-analysis confirmed the significant associations of the presence of bronchiectasis with the natural history, disease course, and outcomes in COPD. The COPD-bronchiectasis phenotype had adverse effects on subjects' health condition and prognosis.

Citing Articles

Occluding mucous airway plugs in patients with obstructive lung diseases: a new treatable trait?.

Agusti A, Aliberti S, Blasi F, Miravitlles M, Papi A ERJ Open Res. 2025; 11(1.

PMID: 39872389 PMC: 11770761. DOI: 10.1183/23120541.00793-2024.


Characteristics of Bronchiectasis Associated with Chronic Obstructive Pulmonary Disease.

Deghdegh K, Boukadoum N, Terra B, Amoura K, Benali R Open Respir Med J. 2023; 16:e187430642203311.

PMID: 37273954 PMC: 10156028. DOI: 10.2174/18743064-v16-e2203311.


Research advances and clinical management of bronchiectasis: Chinese perspective.

Xu J, Gao Y, Song Y, Qu J, Guan W ERJ Open Res. 2022; 8(2).

PMID: 35415184 PMC: 8995535. DOI: 10.1183/23120541.00017-2022.


ROSE: radiology, obstruction, symptoms and exposure - a Delphi consensus definition of the association of COPD and bronchiectasis by the EMBARC Airways Working Group.

Traversi L, Miravitlles M, Martinez-Garcia M, Shteinberg M, Bossios A, Dimakou K ERJ Open Res. 2021; 7(4).

PMID: 34820447 PMC: 8607072. DOI: 10.1183/23120541.00399-2021.


Antimicrobial Resistance in Common Respiratory Pathogens of Chronic Bronchiectasis Patients: A Literature Review.

Inchingolo R, Pierandrei C, Montemurro G, Smargiassi A, Lohmeyer F, Rizzi A Antibiotics (Basel). 2021; 10(3).

PMID: 33804631 PMC: 8003644. DOI: 10.3390/antibiotics10030326.